摘要 |
<p>The present invention features interferon- and ribavirin-free therapies for the treatment of HCV. Preferably, the treatment is over a shorter duration of treatment, such as no more than 12 weeks. In one aspect, the therapies comprise administering at least two direct acting antiviral agents without interferon and ribavirin to a subject with HCV infection. For example, the therapies comprise administering to a subject an effective amounts of therapeutic agent 1, therapeutic agent 2 (or therapeutic agent 3), and an inhibitor of cytochrome P450 (e.g., ritonavir). 6721119_1 (GHMatters) P99394.AU.7 JBORHAM Figure 6C</p> |
申请人 |
ABBVIE IRELAND UNLIMITED COMPANY |
发明人 |
BERNSTEIN, BARRY M.;MENON, RAJEEV M.;KHATRI, AMIT;MENSING, SVEN;DUTTA, SANDEEP;COHEN, DANIEL E.;PODSADECKI, THOMAS J.;BRUN, SCOTT C.;AWNI, WALID M.;DUMAS, EMILY O.;KLEIN, CHERI E. |